DECREASE IN CHILDHOOD NEUROBLASTOMA DEATH IN JAPAN

被引:38
|
作者
HANAWA, Y
SAWADA, T
TSUNODA, A
机构
[1] KYOTO PREFECTURAL UNIV MED,DEPT PEDIAT,KYOTO 602,JAPAN
[2] KANAGAWA CHILDRENS MED CTR,YOKOHAMA,KANAGAWA,JAPAN
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1990年 / 18卷 / 06期
关键词
cancer in children; death statistics; mass screening;
D O I
10.1002/mpo.2950180607
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Death statistics cards under 15 years of age submitted between 1979 and 1987 and coded as malignant neoplasms of organs or sites, in which neuroblastoma might affect, were inspected. A total of 1,037 cases of neuroblastoma death were identified. Total number of neuroblastoma deaths among those under 15 years of age ranged between 118 and 145 from 1979 to 1984. However, after 1985 the number of deaths showed a declining tendency Down to 89 in both 1985 and 1986 and totalling only 93 in 1987. This declining tendency was mostly‐seen among children between 1 to 4 years of age. In this age group, the rate of death in 1987 was about one half of that in 1979; In the other age groups no declining tendency of neuroblastoma death was found. The reason for the decrease in neuroblastoma death among children in Japan may be a result of widespread mass‐screening for neuroblastoma. However, further study is necessary before any final conclusions can be drawn. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:472 / 475
页数:4
相关论文
共 50 条
  • [41] SYNAPTOPHYSIN - AN IMMUNOHISTOCHEMICAL MARKER FOR CHILDHOOD NEUROBLASTOMA
    MIETTINEN, M
    RAPOLA, J
    ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1987, 95 (04): : 167 - 170
  • [42] SURVIVING CHILDHOOD NEUROBLASTOMA: AT WHAT COST?
    Kurkure, Purna
    Dhamankar, Vandana
    Vora, Tushar
    Goswami, Savita
    Dalvi, N.
    Arora, Brijesh
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 830 - 830
  • [43] A Childhood Neuroblastoma with Hypercatecholaminemia: A Case Report
    Xiong, X.
    Yang, L.
    Xiaomin, P.
    Pingping, W.
    Chuchu, F.
    Xiaojun, W.
    Wenjun, W.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S609 - S609
  • [44] NEUROBLASTOMA IN CHILDHOOD - AN EVALUATION OF SURGICAL MANAGEMENT
    KOOP, CE
    KIESEWETTER, WB
    HORN, RC
    PEDIATRICS, 1955, 16 (05) : 652 - 657
  • [45] CERVICAL NEUROBLASTOMA IN CHILDHOOD - BETTER PROGNOSIS
    ORR, JD
    CLINICAL ONCOLOGY, 1978, 4 (04): : 353 - 358
  • [46] Significant decrease expression of pAkt in mass screening neuroblastoma
    Sartelet, H.
    Ohta, S.
    Bareue, S.
    Brevet, M.
    Rougemont, A-L
    Harvey, I.
    Bernard, C.
    Vassal, G.
    LABORATORY INVESTIGATION, 2008, 88 : 334A - 334A
  • [47] Significant decrease expression of pAkt in mass screening neuroblastoma
    Sartelet, H.
    Ohta, S.
    Barette, S.
    Rougemont, A-L
    Harvey, I.
    Bernard, C.
    Vassal, G.
    MODERN PATHOLOGY, 2008, 21 : 334A - 334A
  • [48] Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality
    Nishi, M
    Takeda, T
    Hatae, Y
    Hanai, J
    Fujita, K
    Ichimiya, H
    Tanaka, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (01) : 73 - 78
  • [49] DEATH FROM NEUROBLASTOMA - A CASE REPORT
    FARMAN, JV
    BRITISH JOURNAL OF ANAESTHESIA, 1965, 37 (11) : 883 - &
  • [50] Childhood autism in Japan
    Takei, N
    BRITISH JOURNAL OF PSYCHIATRY, 1996, 169 (05) : 671 - 672